PCSA · Processa Pharmaceuticals, Inc.
$2.62
-0.25 (-8.71%)
At close · Jul 24
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Absent additional funding, we believe that our cash and cash equivalents, along with our digital assets, will not be sufficient to fund our operations for a period of one year or more after the date that these consolidated financial statements are available to be issued based on the timing and amount of our projected net loss from continuing operations and cash to be used in operating activities during that period of time. As a result, substantial doubt exists about our ability to continue as a going concern within one year after the date that these consolidated financial statements are available to be issued.”View the 10-Q filed May 7, 2026
Market Cap
$7.15M
Shares
2.75M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-26 | 11 | $1.89 | $21 |
| 2026-06-25 | 15 | $1.93 | $29 |
| 2026-06-12 | 1,958 | $2.37 | $4,640 |
| 2026-06-04 | 4,411 | $2.80 | $12,351 |
| 2026-06-02 | 1,111 | $2.53 | $2,811 |
| 2026-06-01 | 3,312 | $2.56 | $8,479 |
| 2026-05-29 | 3,827 | $2.64 | $10,103 |
| 2026-05-21 | 34 | $2.66 | $90 |
| 2026-05-19 | 64 | $2.75 | $176 |
| 2026-05-18 | 159 | $2.96 | $471 |
| 2026-05-14 | 2 | $2.55 | $5 |
| 2026-05-12 | 9,621 | $2.69 | $25,880 |
| 2026-05-08 | 524 | $2.87 | $1,504 |
| 2026-05-04 | 28 | $2.55 | $71 |
| 2026-04-27 | 47 | $2.98 | $140 |
Showing 1–15 of 15 settlements